OCUL

OCUL EBITDA Growth

-41.94%TTM

Period ending:

OCUL TTM EBITDA YoY %%
OCUL TTM EBITDA YoY %418.42%-2853.92%
2014-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

OCUL ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 47 observations from Dec 31, 2014 to Jun 30, 2026.

Ocular Therapeutix Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-41.9414%
-55.5088%
-41.8064%
-49.7778%
-67.3449%
-79.5372%
-165.2077%
-180.8917%
-47.5675%
-23.2908%
-7.2869%
-10.3535%
-245.3362%
-503.2026%
-2,537.2441%
36.3902%
74.8685%
89.1296%
101.7386%
8.4882%
-0.2615%
-48.9823%
-87.9253%
-22.3197%
-36.8132%
-39.2477%
-38.9398%
-36.9268%
-30.7159%
-2.2789%
6.5409%
13.9182%
3.9064%
-21.0041%
-41.5042%
-48.9722%
-28.4839%
-15.9703%
-12.9958%
-15.7751%
-38.3409%
-50.8856%
-38.796%
-51.8638%
-57.1105%
-65.0494%
-116.3005%

Compare ebitda growth

All OCUL financial metrics · OCUL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.